Nicht-Steroidal Anti-Entzündung Drogenmarkt GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

Non-Steroidal Anti-Inflammatory Drugs Market, By Indication (Arthritis, Migraine, Ophthalmic Diseases, Others), By Route of Administration(Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), By Geographie (Nordamerika, Lateinamerika, Asien-Pazifik, Europa, Mittlerer Osten, und Afrika). Der Bericht bietet den Wert (in Mrd. USD) für die oben genannten Segmente.

Competitive overview of Nicht-Steroidal Anti-Entzündung Drogenmarkt

Zu den wichtigsten Akteuren des nicht-steroidalen Antiinflammatorikmarktes gehören Pfizer Inc., Johnson & Johnson Services, Inc., Bayer AG, Sanofi, GSK plc, Heron Therapeutics, Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group PLC und Assertio Holdings, Inc.

Nicht-Steroidal Anti-Entzündung Drogenmarkt Leaders

  • Pfizer Inc.
  • Johnson & Johnson Dienstleistungen, Inc.
  • Bayer AG
  • Sanofi
  • GSK plc
*Disclaimer: Major players are listed in no particular order.

Nicht-Steroidal Anti-Entzündung Drogenmarkt - Competitive Rivalry, 2023

Market Concentration Graph

Nicht-Steroidal Anti-Entzündung Drogenmarkt

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

Nicht-Steroidal Anti-Entzündung Drogenmarkt Report Snapshots

Buy Now